The concerns and best practices related to long term, “anti aging” or “hormone optimization” use are different from short term supraphysiologic “contest prep” use. So different I think they’re almost two different subjects, even though there’s some crossover.
Long term, physiological range use has a lot more scientific data behind it, even if we’re talking about “off label” use since, like TRT, is supposed to be reserved for people with a formally defined “deficiency”, and not used to push levels of the respective hormone to “optimum levels”. (Or slightly above).
Unfortunately this isn’t a topic with a lot of “light reading” available. Not exactly something non endocrinologists have an interest in. Type IIx “Bolus” is the only non-physician target book I’m aware of.
This guideline document is a little dense, but there are lots of gems in it a scientifically literate layman can understand, so it’s worth browsing.
Just a few notes that might make it easier to navigate.
There’s a chart for all the acronyms used, so note the page it’s on so you can go back and check. For example, “SDS”, is “standard deviation score”, or how far above or below average, in this context, IGF is. (-2 to +2 is physiological). This is equivalent to IGF Z score, by the way.
You’ll see “evidence grades” for each recommendation. This is a common way guidelines tell you how strong the evidence is that backs up a particular piece of information or recommended practice. Everything in guidelines like this has to be backed by evidence. They provide references so you can dig into the studies that established that evidence, and go down whatever rabbit hole that catches your interest.
Here’s an example of info that most people can understand if you dig deeper into this, just so you don’t get discouraged if the first part of the document seems incomprehensible:
View attachment 362153
Enjoy, and consider sharing anything you find interesting. It’s unlikely any one of us will catch everything useful in the guideline: